These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1948130)

  • 21. The role of interferon alfa in the treatment of metastatic melanoma.
    Legha SS
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S24-31. PubMed ID: 9122731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamics.
    Mick R; Vokes EE; Lestingi TM; Gray-Stern W; Fleming GF; Schilsky RL; Ratain MJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):349-59. PubMed ID: 8653998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the clinical studies of alpha-interferon in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):18-29. PubMed ID: 1948125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay.
    Salmon SE; Young L; Scuderi P; Clark B
    J Clin Oncol; 1987 Nov; 5(11):1816-21. PubMed ID: 3119787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinoma.
    Honma Y; Kasukabe T; Yamori T; Kato N; Sassa T
    Gynecol Oncol; 2005 Dec; 99(3):680-8. PubMed ID: 16112179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.
    Danhauser LL; Freimann JH; Gilchrist TL; Gutterman JU; Hunter CY; Yeomans AC; Markowitz AB
    J Clin Oncol; 1993 Apr; 11(4):751-61. PubMed ID: 8478667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
    Wigington DP; Urben CM; Strugnell SA; Knutson JC
    Anticancer Res; 2004; 24(5A):2905-12. PubMed ID: 15517895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon caused alterations of human cell response to bleomycin in vitro.
    Giannoylaki H; Havredaki M
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):339-42. PubMed ID: 7516651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M; Esmaeili-Mahani S
    Fundam Clin Pharmacol; 2014 Aug; 28(4):414-22. PubMed ID: 23837575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.
    Schwartz EL; Baptiste N; O'Connor CJ; Wadler S; Otter BA
    Cancer Res; 1994 Mar; 54(6):1472-8. PubMed ID: 8137250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
    Morikawa K; Fidler IJ
    J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
    Nagasawa M; Ishii S; Kariya Y; Itoh O; Yamamoto H; Kawaharajo K; Takeuchi T
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):633-8. PubMed ID: 2108612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
    Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
    Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.
    Harrison SD; Stevens JJ; Waud WR; Dykes DJ; Schmid SM; Griswold DP
    J Biol Response Mod; 1990 Aug; 9(4):395-400. PubMed ID: 2118561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
    Akutsu M; Suzuki K; Tsunoda S; Kano Y
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Hattori T; Satoh M; Terashima Y; Nishimura T; Akimoto M
    Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of in vitro treatment of chronic myelogenous leukemia cell line, K562 cells, using 4-hydroperoxycyclophosphamide, alpha-interferon and gamma-interferon.
    Lee JT; Park S; Lee JH; Kim BK; Kim NK
    J Korean Med Sci; 1996 Feb; 11(1):26-32. PubMed ID: 8703367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
    Yu LL; Wu JG; Dai N; Yu HG; Si JM
    Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.